extended phenytoin sodium
Generic: phenytoin sodium
Labeler: american health packagingDrug Facts
Product Profile
Brand Name
extended phenytoin sodium
Generic Name
phenytoin sodium
Labeler
american health packaging
Dosage Form
CAPSULE
Routes
Active Ingredients
phenytoin sodium 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
60687-841
Product ID
60687-841_2d7feada-3c36-9b2e-e063-6294a90ab409
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204309
Listing Expiration
2026-12-31
Marketing Start
2025-02-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
60687841
Hyphenated Format
60687-841
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
extended phenytoin sodium (source: ndc)
Generic Name
phenytoin sodium (source: ndc)
Application Number
ANDA204309 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 100 BLISTER PACK in 1 CARTON (60687-841-01) / 1 CAPSULE in 1 BLISTER PACK (60687-841-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2d7feada-3c36-9b2e-e063-6294a90ab409", "openfda": {"unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["5b64cb11-673a-41ec-9b2a-1e194ae5eb0c"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (60687-841-01) / 1 CAPSULE in 1 BLISTER PACK (60687-841-11)", "package_ndc": "60687-841-01", "marketing_start_date": "20250206"}], "brand_name": "Extended Phenytoin Sodium", "product_id": "60687-841_2d7feada-3c36-9b2e-e063-6294a90ab409", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "60687-841", "generic_name": "Phenytoin Sodium", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Extended Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA204309", "marketing_category": "ANDA", "marketing_start_date": "20250206", "listing_expiration_date": "20261231"}